NCT05313477View on ClinicalTrials.gov

The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

November 30, 2023

Conditions
Parathyroid HormoneTenofovir Disoproxil FumarateChronic Hepatitis B VirusVitamin D
Interventions
DRUG

Ergocalciferol Capsules

Depend on initial 25(OH) vitamin D level If \<10ng/mL, 60000U of Ergocalciferol capsules per week If 10-19.9ng/mL, 40000U of Ergocalciferol capsules per week If \>20 ng/mL, 20000U of Ergocalciferol capsule per week

DRUG

Calcium carbonate

1000mg of Calcium carbonate daily

Trial Locations (1)

10700

Faculty of Medicine, Siriraj Hospital, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER